Angel Pharmaceuticals Gains CDE Approval for Mupadolimab Phase I/Ib Study
China-based Angel Pharmaceuticals Ltd has announced that it has received approval from the Center for...
Biotech
YiChang HEC Reports Strong Recovery in 2022 Interim Results
China-based YiChang HEC ChangJiang Pharmaceutical Co., Ltd (HKG: 1558) has released its 2022 interim report,...
Gluetacs Therapeutics Files IND for Molecular Glue Degrading Agent in China
Gluetacs Therapeutics has reported filing an Investigational New Drug (IND) application for its first molecular...
Global Cord Blood Corporation Appoints Liquidators Amid Shareholder Dispute
Global Cord Blood Corporation (OTCMKTS: CORBF) has announced that the Grand Court of the Cayman...
Hansoh Pharmaceutical Licenses KiOmedine One for Osteoarthritis Treatment
China-based Hansoh Pharmaceutical Group Co., Ltd (HKG: 3692) has announced a licensing agreement with Belgium’s...
Shuangcheng Pharma Licenses US Rights for Paclitaxel Injection to Meitheal
China’s Hainan Shuangcheng Pharmaceutical Co., Ltd (SHA: 002693) has announced a licensing and supply agreement...
Menarini and OrigiMed Partner on Pan-Cancer Single-Cell Diagnostic Platform
Italy’s Menarini Group has formed a strategic partnership with China-based precision medicine firm OrigiMed to...
InnoCare Pharma’s IPO Raises $411M for Drug R&D and Platform Upgrade
China-based InnoCare Pharma (HKG: 9969) has completed an initial public offering (IPO) of 265 million...
AIM Vaccine Plans IPO to Fund Vaccine R&D and Pipeline Expansion
China-based AIM Vaccine Co., Ltd plans to make an initial public offering (IPO) of 9.71...
Shandong Luoxin Partners with Shanghai Pharma for Strategic Services
China-based Shandong Luoxin Pharmaceutical Group Stock Co., Ltd (SHE: 002793) has announced a partnership with...
Zelgen Biopharmaceuticals Gains NMPA Approval for Jacktinib Clinical Trial in SLE
Suzhou Zelgen Biopharmaceuticals Co., Ltd (SHA: 688266) has announced that it has received clinical trial...
F-star Therapeutics’ Takeover by Sino Biopharmaceutical Delayed Amid CFIUS Review
UK-based biotech F-star Therapeutics Inc. (NASDAQ: FSTX) announced in a stock exchange press release that...
Merck KGaA Opens Viral Clearance Lab in Shanghai’s Biologics Testing Center
German pharmaceutical giant Merck KGaA has opened a viral clearance (VC) laboratory as part of...
Kamari Pharma Completes $8M Investment from Chinese Fund GIBF2
Israel-based Kamari Pharma has announced the completion of an $8 million investment from the Chinese...
WuXi Biologics Partners with Elpiscience for Macromolecule Development
China-based Contract Research, Development, and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) has announced multiple...
Zhong’ao Biopharmaceutical Secures Series A Funding for Cancer and HPV-Related Disease R&D
China-based Zhong’ao Biopharmaceutical Technology (Guangdong) Co., Ltd. has reportedly raised an undisclosed amount of money...
Apollomics Set to Merge with Maxpro Capital for Nasdaq Listing
Sino-US biotech Apollomics Inc. has revealed plans to merge with the special purpose acquisition company...
Antengene Expands to Australia with New Melbourne Office
China-based biotech firm Antengene (HKG: 6996) announced the opening of its new office in Melbourne,...
Zhonghong Pulin Partners with Shanghai Pharma for Logistics and Distribution
China-based Zhonghong Pulin Medical Product Co., Ltd (SHE: 300981) has entered into a partnership with...
Luye Life Sciences Partners with Uzbekistan to Establish Vaccine Center
China-based Luye Life Sciences Group has struck a partnership with the Ministry of Innovation and...